Cargando…
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10
Despite many decades of drug development, effective therapies for neuropathic pain remain elusive. The recent recognition of spinal cord glia and glial pro-inflammatory cytokines as important contributors to neuropathic pain suggests an alternative therapeutic strategy; that is, targeting glial acti...
Autores principales: | Milligan, Erin D, Sloane, Evan M, Langer, Stephen J, Cruz, Pedro E, Chacur, Marucia, Spataro, Leah, Wieseler-Frank, Julie, Hammack, Sayamwong E, Maier, Steven F, Flotte, Terence R, Forsayeth, John R, Leinwand, Leslie A, Chavez, Raymond, Watkins, Linda R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079940/ https://www.ncbi.nlm.nih.gov/pubmed/15813997 http://dx.doi.org/10.1186/1744-8069-1-9 |
Ejemplares similares
-
Size does matter: overcoming the adeno-associated virus packaging limit
por: Flotte, Terence R
Publicado: (2000) -
Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain: Harnessing innate immunity to enhance gene therapy
por: Sloane, Evan, et al.
Publicado: (2009) -
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023) -
Neural mobilization reverses behavioral and cellular changes that characterize neuropathic pain in rats
por: Santos, Fabio M, et al.
Publicado: (2012) -
Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus
por: Tang, Qiushi, et al.
Publicado: (2020)